Wells Fargo’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.3K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $29.4K | Buy |
|
|||||
|
2023
Q4 | $35.5K | Buy |
|
|||||
|
2023
Q3 | $26.4K | Sell |
|
|||||
|
2023
Q2 | $42K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $0 | Hold |
|
|||||
|
2018
Q4 | $0 | Sell |
|
|||||
|
2018
Q3 | $73K | Hold |
|
|||||
|
2018
Q2 | $43K | Hold |
|
|||||
|
2018
Q1 | $54K | Hold |
|
|||||
|
2017
Q4 | $67K | Hold |
|
|||||
|
2017
Q3 | $58K | Hold |
|
|||||
|
2017
Q2 | $84K | Hold |
|
|||||
|
2017
Q1 | $137K | Buy |
|
|||||
|
2016
Q4 | $0 | Hold |
|
|||||
|
2016
Q3 | $0 | Hold |
|
|||||
|
2016
Q2 | $0 | Hold |
|
|||||
|
2016
Q1 | $1K | Hold |
|
|||||
|
2015
Q4 | $1K | Hold |
|
|||||
|
2015
Q3 | $1K | Buy |
|